Page 18 - 《中国药房》2021年5期

我国医疗机构处方前置审核开展的现状分析 Δ

#
李汶睿 ，李 頔，赵春景，钱 妍（重庆医科大学附属第二医院药学部，重庆 400010）
＊
中图分类号 R952 文献标志码 A 文章编号 1001-0408（2021）05-0524-06
DOI 10.6039/j.issn.1001-0408.2021.05.03

摘 要 目的：了解我国医疗机构处方前置审核工作的开展现状，为医疗机构提升前置审核工作质量提供参考。方法：计算机检
索PubMed、Cochrane图书馆、Embase（Ovid平台）、中国知网、中国生物医学文献数据库、维普网和万方数据库，检索时限均为建库
起至2020年3月，收集我国医疗机构开展处方前置审核工作情况的研究。对符合纳入与排除标准的文献进行资料提取后，进行描
述性分析。结果：共纳入38篇文献，涉及医疗机构29所，其中三级甲等医疗机构25所（86.21％）、综合性医疗机构22所（75.86％），
工作开展时间为 2007－2019 年；84.62％的医疗机构采用“系统审核+人工复核”的审核模式，审核处方主要为门（急）诊处方
（76.00％），采用该模式的医疗机构主要采取审方药师对系统拦截的问题处方再次复核的模式；8所医疗机构平均问题处方人工复
核时间在60 s以内；16所医疗机构报道的审方药师人数为1～8人，1所医疗机构报道的审方药师学历为本科及以上，6所医疗机构
报道的审方药师职称为中级及以上（83.33％），11所医疗机构报道以专职审方岗位为主（90.91％）。处方前置审核工作的问题处
方干预成功率为93.99％，且可提高医疗机构处方合格率。结论：我国医疗机构处方前置审核工作取得了一定效果，但仍面临信息
系统不完善、审方药师能力不足以及医师药师沟通不畅等问题，将是未来开展处方前置审核工作需注意的方面。
关键词 处方前置审核；医疗机构；现状

Current Situation Analysis of Pre-prescription Review in Medical Institutions in China
LI Wenrui，LI Di，ZHAO Chunjing，QIAN Yan（Dept. of Pharmacy，the Second Affiliated Hospital of Chongqing
Medical University，Chongqing 400010，China）

ABSTRACT OBJECTIVE：To know about the current situation of pre-prescription review in medical institutions in China，and
provide reference for quality improvement of pre-prescription review in medical institutions. METHODS：Retrieved from PubMed，
the Cochrane library，EMbase（Ovid platform），CNKI，CBM，VIP and Wanfang databases，the studies about pre-prescription
review in medical institutions in China were collected during the inception to Mar. 2020. After data extraction of the literatures met
the inclusion and exclusion criteria，descriptive analysis was used. RESULTS：A total of 38 literatures were included，involving 29
medical institutions，of which 25 were third-grade class-A medical institutions（86.21％），22 comprehensive medical institutions
（75.86％）；pre-prescription review was carried out from 2007 to 2019. Totally 84.62％ of medical institutions adopted the mode of
“systematic review + manual review”，and the main audited prescriptions were outpatient （emergency） prescriptions （76.00％）.
Medical institutions adopting this mode mainly adopted the mode that auditing pharmacists rechecked the problem prescriptions
intercepted by the system. The average manual review time of problem prescriptions in 8 medical institutions was within 60 s；the
number of auditing pharmacists in 16 reported medical institutions ranged from 1 to 8，and educational degree of auditing
pharmacists in 1 reported medical institution were bachelor degree or above. Their professional titles of 6 reported medical
institutions were junior or above（83.33％）. Eleven medical institutions had full-time auditing posts（90.91％）. Success rate of
problem prescription intervention was 93.99％ ；pre-prescription review could increase the qualification rate of prescription.
CONCLUSION：The pre-prescription review in medical institutions in China has achieved certain results，but still faces some
problems，such as imperfect information system，insufficient ability of auditing pharmacists and poor communication between
doctors and pharmacists，which will be the aspects that should
Δ 基金项目：国家自然科学基金资助项目（No.8140293727）；北京
康盟慈善基金会临床与基础研究专项（No.HS202003） be paid attention to in the future.
＊硕士。研究方向：循证药学。电话：023-63693137。E-mail： KEYWORDS Pre-prescription review；Medical institutions；
wenruili55@163.com Current Situation
# 通信作者：副主任中药师，硕士生导师，硕士。研究方向：药事
管理、临床药学。电话：023-63693109。E-mail：cqqianyan@hospital.
cqmu.edu.cn

·524 · China Pharmacy 2021 Vol. 32 No. 5 中国药房 2021年第32卷第5期